For instance, the treatment of HepG2 cells with GW2974, an EGFR inhibitor, induced the attenuation of the downstream PI3K/AKT/mTOR signaling pathway, resulting in decreased cell proliferation and increased apoptosis in HCC cells [41]. Here, EGFR is linked to hepatocellular carcinoma.